Table 1 Comparison of the nucleotide sequences of field isolates from Taiwan with commercial CDV vaccines using the CDV M-F UTR and part of the F gene (nucleotides 4325-5325)
Percentage identity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | TW-1 | TW-2 | TW-3 | TW-4 | TW-5 | TW-6 | TW-7 | Vacc N | Vacc P | Vacc Q |
TW-1 | Â | 98.5 | 99.3 | 98.1 | 97.6 | 98.0 | 98.1 | 83.3 | 93.6 | 85.1 |
TW-2 | 1.5 | Â | 98.6 | 97.8 | 97.9 | 97.7 | 97.8 | 82.7 | 93.8 | 85.0 |
TW-3 | 0.7 | 1.4 | Â | 98.2 | 97.7 | 98.1 | 98.2 | 82.9 | 93.5 | 84.8 |
TW-4 | 1.9 | 2.2 | 1.8 | Â | 96.9 | 99.9 | 100.0 | 83.1 | 93.5 | 84.9 |
TW-5 | 2.4 | 2.1 | 2.3 | 3.2 | Â | 96.8 | 96.9 | 82.5 | 93.2 | 85.0 |
TW-6 | 2.0 | 2.3 | 1.9 | 0.1 | 3.3 | Â | 99.9 | 83.0 | 93.4 | 84.8 |
TW-7 | 1.9 | 2.2 | 1.8 | 0.0 | 3.2 | 0.1 | Â | 83.1 | 93.5 | 84.9 |
Vacc N | 19.3 | 20.2 | 19.9 | 19.6 | 20.4 | 19.7 | 19.6 | Â | 86.2 | 96.3 |
Vacc P | 6.7 | 6.5 | 6.8 | 6.8 | 7.2 | 7.0 | 6.8 | 15.6 | Â | 88.9 |
Vacc Q | 16.9 | 17.1 | 17.3 | 17.2 | 17.0 | 17.3 | 17.2 | 3.8 | 12.2 | Â |
Divergence | ||||||||||